Key result
Hemodialysis or hemodiafiltration successfully cured acute renal failure in all 6 patients with neuroleptic malignant syndrome, reducing mean serum creatinine from 9.1 to /dL.
Why the study?
Does hemodialysis or hemodiafiltration improve acute renal failure in patients with neuroleptic malignant syndrome?
Case Report (n=6)
Does hemodialysis or hemodiafiltration improve acute renal failure in patients with neuroleptic malignant syndrome?
Hemodialysis or hemodiafiltration successfully treated myoglobulinemic acute renal failure associated with neuroleptic malignant syndrome in a small case series.
Answers are grounded in this paper and cite their sources.
Supports hemodialysis for NMS renal failure; hypothesis-generating case series requiring prospective trials.
Neuroleptic malignant syndrome is a rare but potentially lethal, rare reaction to neuroleptics which is characterized by altered levels of consciousness, extrapyramidal effects, autonomic instability, hyperthermia, and elevated serum creatine phosphokinase levels. The most serious complication of neuroleptic malignant syndrome is acute renal failure. We investigated six cases of neuroleptic malignant syndrome associated with myoglobulinemic acute renal failure due to rhabdomyolysis and effect of hemodialysis or hemodiafiltration. The patients were five males and one female with a mean age of 43.5 yr. All of the patients, who developed acute renal failure induced from rhabdomyolysis, had previously received butyrophenone (haloperidol), phenothiazine, benzamide, iminomide, benzisoxazole, antidepressants, and hypnotics (benzodiazepine and barbiturate) for the treatment of schizophrenia. The clinical manifestations of neuroleptic malignant syndrome were characterized by altered consciousness, muscle rigidity and weakness, fever, and excessive perspiration. The peak laboratory data were blood urea nitrogen 102 +/- 26 (mean +/- SD) mg/dL, serum creatinine 9.1 +/- 2.1 mg/dL, serum creatine phosphokinase 229,720 +/- 289,940 IU/L, and all of them developed oliguric acute renal failure. Dantrolene sodium administration was given to five cases and hemodialysis or hemodiafiltration was performed in all of them. The serum creatinine level after hemodialysis or hemodiafiltration was 1.4 +/- 1.0 mg/dL. All patients were successfully cured of acute renal failure by hemodialysis or hemodiafiltration. As a result, myoglobulinemic acute renal failure associated with neuroleptic malignant syndrome was successfully treated by hemodialysis or hemodiafiltration.
No takes yet. Share an insight, caveat, or question.
Sanai et al. (2006) conducted a case report in Neuroleptic malignant syndrome associated with myoglobulinemic acute renal failure (n=6). Hemodialysis or hemodiafiltration was evaluated on Cure of acute renal failure. Hemodialysis or hemodiafiltration successfully cured acute renal failure in all 6 patients with neuroleptic malignant syndrome, reducing mean serum creatinine from 9.1 to /dL.
Synapse has enriched 10 related papers. Consider them for comparative context: